Sfoglia per Autore
molecular evaluation of minimal residual disease in multiple myeloma
2001-01-01 Galimberti, Sara; Guerrini, Francesca; Palumbo, Ga; Giustolisi, R; Petrini, Mario
quantitative molecular detection of IgH rearrangement in multiple myeloma: comparison of two innovative techniques
2001-01-01 Galimberti, Sara; Guerrini, Francesca; Palumbo, Ga; Giustolisi, R; Petrini, Mario
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma
2002-01-01 Galimberti, Sara; Marasca, R; Caracciolo, F; Fazzi, R; Papineschi, Federico; Benedetti, E; Guerrini, Francesca; Morabito, F; Oliva, E; DI RENZO, N; Federico, M; Petrini, Mario; Torelli, G.
Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients
2003-01-01 Galimberti, Sara; Morabito, F; Guerrini, Francesca; Palumbo, Ga; Azzara', Antonio; Martino, M; Benedetti, E; DI RAIMONDO, F; Petrini, Mario
Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab
2003-01-01 Galimberti, Sara; Guerrini, Francesca; Morabito, F; Palumbo, Ga; DI RAIMONDO, F; Papineschi, Federico; Caracciolo, F; Fazzi, R; Cervetti, G; Cuzzocrea, A; Petrini, Mario
FLT3 mutations do not influence MDR-1 gene expression in acute myeloid leukemia
2003-01-01 Galimberti, Sara; Rossi, ANNA MARIA; Palumbo, Ga; Morabito, F; Guerrini, Francesca; Vincelli, I; Fazzi, R; Santini, V; Petrini, Mario
The clinical relevance of the expression of several multidrug-resistant-related genes in patients with primary acute myeloid leukemia
2003-01-01 Galimberti, Sara; Testi, Rossana; Guerrini, Francesca; Fazzi, R; Petrini, Mario
Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H).
2004-01-01 Galimberti, Sara; Cervetti, G; Cecconi, N; Fazzi, R; Pacini, Simone; Guerrini, Francesca; Manetti, C; Caracciolo, F; Petrini, Mario
Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis
2004-01-01 Galimberti, Sara; Guerrini, Francesca; Carulli, Giovanni; Fazzi, R; Palumbo, Ga; Morabito, F; Petrini, Mario
Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients
2004-01-01 Galimberti, Sara; Guerrini, Francesca; Palumbo, Ga; Consoli, U; Fazzi, R; Morabito, F; Santini, V; Petrini, Mario
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation
2005-01-01 Galimberti, Sara; Benedetti, E; Morabito, F; Papineschi, Federico; Callea, V; Fazzi, R; Stelitano, C; Andreazzoli, F; Guerrini, Francesca; Ciabatti, Elena; Martino, M; Nobile, F; Iacopino, P; Petrini, Mario
Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment
2005-01-01 Galimberti, Sara; Cervetti, G; Guerrini, Francesca; Testi, Rossana; Pacini, Simone; Fazzi, R; Simi, P; Petrini, Mario
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen. Leuk Lymphoma
2007-01-01 Galimberti, Sara; Nagy, B; Benedetti, E; Pacini, Simone; Brizzi, S; Caracciolo, F; Papineschi, Federico; Ciabatti, Elena; Guerrini, Francesca; Fazzi, R; Canestraro, Martina; Petrini, Mario
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen
2007-01-01 Galimberti, Sara; Nagy, B; Benedetti, E; Pacini, Simone; Brizzi, S; Caracciolo, F; Papineschi, Federico; Ciabatti, Elena; Guerrini, Francesca; Fazzi, R; Canestraro, Martina; Petrini, Mario
Molecular detection of GNNK- and GNNK+ c-kit isoforms: a new tool for risk stratification in adult acute myeloid leukaemia
2007-01-01 Guerrini, Francesca; Galimberti, Sara; Ciabatti, Elena; Brizzi, S; Testi, Rossana; Pollastrini, A; Falini, B; Petrini, Mario
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines
2008-01-01 Galimberti, Sara; Canestraro, Martina; Khan, R; Buda, Gabriele; Orciuolo, E; Guerrini, Francesca; Fazzi, R; Maffei, Riccardo; Marasca, R; Petrini, Mario
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines
2008-01-01 Galimberti, Sara; Canestraro, Martina; Khan, R; Buda, Gabriele; Orciuolo, E; Guerrini, Francesca; Fazzi, R; Maffei, R; Marasca, R; Petrini, Mario
PLATELET-DERIVED GROWTH FACTOR BETA RECEPTOR (PDGFRB) GENE IS REARRANGED IN A SIGNIFICANT PERCENTAGE OF MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE
2009-01-01 Galimberti, Sara; Ferreri, Mi; Simi, P; Azzara', Antonio; Baratè, C; Fazzi, R; Cecconi, N; Cervetti, G; Guerrini, Francesca; Petrini, Mario
Platelet-derived growth factor beta receptor (PDGFRB) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotype
2009-01-01 Galimberti, Sara; Ferreri, Mi; Simi, P; Azzara', Antonio; Baratè, C; Fazzi, R; Cecconi, N; Cervetti, G; Guerrini, Francesca; Petrini, Mario
Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line
2009-01-01 Galimberti, Sara; Canestraro, Martina; Maffei, R; Marasca, R; Guerrini, Francesca; Piaggi, Simona; Ciabatti, Elena; Petrini, Mario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| molecular evaluation of minimal residual disease in multiple myeloma | 1-gen-2001 | Galimberti, Sara; Guerrini, Francesca; Palumbo, Ga; Giustolisi, R; Petrini, Mario | |
| quantitative molecular detection of IgH rearrangement in multiple myeloma: comparison of two innovative techniques | 1-gen-2001 | Galimberti, Sara; Guerrini, Francesca; Palumbo, Ga; Giustolisi, R; Petrini, Mario | |
| The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma | 1-gen-2002 | Galimberti, Sara; Marasca, R; Caracciolo, F; Fazzi, R; Papineschi, Federico; Benedetti, E; Guerrini, Francesca; Morabito, F; Oliva, E; DI RENZO, N; Federico, M; Petrini, Mario; Torelli, G. | |
| Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients | 1-gen-2003 | Galimberti, Sara; Morabito, F; Guerrini, Francesca; Palumbo, Ga; Azzara', Antonio; Martino, M; Benedetti, E; DI RAIMONDO, F; Petrini, Mario | |
| Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab | 1-gen-2003 | Galimberti, Sara; Guerrini, Francesca; Morabito, F; Palumbo, Ga; DI RAIMONDO, F; Papineschi, Federico; Caracciolo, F; Fazzi, R; Cervetti, G; Cuzzocrea, A; Petrini, Mario | |
| FLT3 mutations do not influence MDR-1 gene expression in acute myeloid leukemia | 1-gen-2003 | Galimberti, Sara; Rossi, ANNA MARIA; Palumbo, Ga; Morabito, F; Guerrini, Francesca; Vincelli, I; Fazzi, R; Santini, V; Petrini, Mario | |
| The clinical relevance of the expression of several multidrug-resistant-related genes in patients with primary acute myeloid leukemia | 1-gen-2003 | Galimberti, Sara; Testi, Rossana; Guerrini, Francesca; Fazzi, R; Petrini, Mario | |
| Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H). | 1-gen-2004 | Galimberti, Sara; Cervetti, G; Cecconi, N; Fazzi, R; Pacini, Simone; Guerrini, Francesca; Manetti, C; Caracciolo, F; Petrini, Mario | |
| Significant co-expression of WT1 and MDR1 genes in acute myeloid leukemia patients at diagnosis | 1-gen-2004 | Galimberti, Sara; Guerrini, Francesca; Carulli, Giovanni; Fazzi, R; Palumbo, Ga; Morabito, F; Petrini, Mario | |
| Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients | 1-gen-2004 | Galimberti, Sara; Guerrini, Francesca; Palumbo, Ga; Consoli, U; Fazzi, R; Morabito, F; Santini, V; Petrini, Mario | |
| Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation | 1-gen-2005 | Galimberti, Sara; Benedetti, E; Morabito, F; Papineschi, Federico; Callea, V; Fazzi, R; Stelitano, C; Andreazzoli, F; Guerrini, Francesca; Ciabatti, Elena; Martino, M; Nobile, F; Iacopino, P; Petrini, Mario | |
| Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment | 1-gen-2005 | Galimberti, Sara; Cervetti, G; Guerrini, Francesca; Testi, Rossana; Pacini, Simone; Fazzi, R; Simi, P; Petrini, Mario | |
| Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen. Leuk Lymphoma | 1-gen-2007 | Galimberti, Sara; Nagy, B; Benedetti, E; Pacini, Simone; Brizzi, S; Caracciolo, F; Papineschi, Federico; Ciabatti, Elena; Guerrini, Francesca; Fazzi, R; Canestraro, Martina; Petrini, Mario | |
| Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen | 1-gen-2007 | Galimberti, Sara; Nagy, B; Benedetti, E; Pacini, Simone; Brizzi, S; Caracciolo, F; Papineschi, Federico; Ciabatti, Elena; Guerrini, Francesca; Fazzi, R; Canestraro, Martina; Petrini, Mario | |
| Molecular detection of GNNK- and GNNK+ c-kit isoforms: a new tool for risk stratification in adult acute myeloid leukaemia | 1-gen-2007 | Guerrini, Francesca; Galimberti, Sara; Ciabatti, Elena; Brizzi, S; Testi, Rossana; Pollastrini, A; Falini, B; Petrini, Mario | |
| Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines | 1-gen-2008 | Galimberti, Sara; Canestraro, Martina; Khan, R; Buda, Gabriele; Orciuolo, E; Guerrini, Francesca; Fazzi, R; Maffei, Riccardo; Marasca, R; Petrini, Mario | |
| Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines | 1-gen-2008 | Galimberti, Sara; Canestraro, Martina; Khan, R; Buda, Gabriele; Orciuolo, E; Guerrini, Francesca; Fazzi, R; Maffei, R; Marasca, R; Petrini, Mario | |
| PLATELET-DERIVED GROWTH FACTOR BETA RECEPTOR (PDGFRB) GENE IS REARRANGED IN A SIGNIFICANT PERCENTAGE OF MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE | 1-gen-2009 | Galimberti, Sara; Ferreri, Mi; Simi, P; Azzara', Antonio; Baratè, C; Fazzi, R; Cecconi, N; Cervetti, G; Guerrini, Francesca; Petrini, Mario | |
| Platelet-derived growth factor beta receptor (PDGFRB) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotype | 1-gen-2009 | Galimberti, Sara; Ferreri, Mi; Simi, P; Azzara', Antonio; Baratè, C; Fazzi, R; Cecconi, N; Cervetti, G; Guerrini, Francesca; Petrini, Mario | |
| Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line | 1-gen-2009 | Galimberti, Sara; Canestraro, Martina; Maffei, R; Marasca, R; Guerrini, Francesca; Piaggi, Simona; Ciabatti, Elena; Petrini, Mario |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile